Published
La contratación de servicio de determinación genómico tumoral, diseñado para establecer alteraciones en tumores sólidos e identificar terapias guiadas molecularmente con potencial beneficio para el paciente y el nivel de evidencia que lo soporta conforme a escalas universalmente conocidas (ESCAT, NCCN). El servicio está previsto para que se realice en 1.775 muestras (410 test de tejido sólido embebido en parafina y 1.365 test de biopsia líquida).
Notice number: FIB 2026/023
KEY INFORMATION
- Submission deadline
- • Nov 5, 2026
- Location
- 🇪🇸 Spain
- Contracting authority
- Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre
- Accepted Languages
- Spanish
- Tender type
- Contract Value
- Published date
- Sep 29, 2026
TENDER DESCRIPTION
The contracting of a tumour genomic determination service, designed to establish alterations in solid tumours and to identify molecularly guided therapies with potential benefit for the patient and the level of evidence supporting them in accordance with universally known scales (ESCAT, NCCN). The service is planned to be carried out on 1,775 samples (410 tests of solid tissue embedded in paraffin and 1,365 liquid biopsy tests).
TENDER BRIEF
Login to view all answers and insights
Unlock tender brief for freeTENDER DOCUMENTS
DIRECTORY • 1 FILE
- PLACSP entryLINK
Login to view and download all tender documents
Unlock documents for freeASK AI ABOUT THIS TENDER
Can a foreign company apply?
Yes, foreign companies can apply as long as they meet all the requirements set out in the procurement documents.
Login to ask more questions.
Unlock AI tender chat for freeUnlock your tender workflow
Run your first search, evaluate the results, save a daily monitor and start building a pipeline of tenders worth pursuing.